Precision BioSciences, Inc.
DTIL
$4.71
$0.020.43%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 86.31M | 101.20M | 123.57M | 137.77M | 116.68M |
Total Receivables | 1.70M | 1.55M | 13.82M | 13.30M | 12.80M |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 6.44M | 7.11M | 5.67M | 9.25M | 5.98M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 538.00K | 660.00K | 979.00K | 506.00K | 906.00K |
Total Current Assets | 94.99M | 110.52M | 144.04M | 160.83M | 136.36M |
|
|||||
Total Current Assets | 94.99M | 110.52M | 144.04M | 160.83M | 136.36M |
Net Property, Plant & Equipment | 10.18M | 10.96M | 11.92M | 13.27M | 14.60M |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 622.00K | 388.00K | 375.00K | 386.00K | 400.00K |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 27.39M | 28.19M | 6.27M | 7.06M | 5.22M |
Total Assets | 136.39M | 153.26M | 165.80M | 184.74M | 159.78M |
|
|||||
Total Accounts Payable | 1.31M | 958.00K | 1.14M | 1.14M | 2.97M |
Total Accrued Expenses | 7.20M | 6.89M | 4.35M | 1.88M | 6.54M |
Short-term Debt | -- | -- | 22.49M | 22.46M | 22.41M |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 1.32M | 1.28M | 1.22M | 1.18M | 1.13M |
Total Finance Division Other Current Liabilities | 5.15M | 2.86M | 3.75M | 6.68M | 16.94M |
Total Other Current Liabilities | 5.15M | 2.86M | 3.75M | 6.68M | 16.94M |
Total Current Liabilities | 14.98M | 11.98M | 32.96M | 33.34M | 49.99M |
|
|||||
Total Current Liabilities | 14.98M | 11.98M | 32.96M | 33.34M | 49.99M |
Long-Term Debt | 22.32M | 22.28M | -- | -- | -- |
Short-term Debt | -- | -- | 22.49M | 22.46M | 22.41M |
Capital Leases | 6.40M | 6.75M | 7.09M | 7.41M | 7.72M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 36.29M | 47.38M | 51.04M | 106.79M | 83.21M |
Total Liabilities | 80.00M | 88.39M | 91.09M | 147.54M | 140.92M |
|
|||||
Common Stock & APIC | 539.81M | 530.54M | 523.96M | 519.20M | 509.44M |
Retained Earnings | -482.46M | -464.72M | -448.29M | -481.04M | -489.63M |
Treasury Stock & Other | -952.00K | -952.00K | -952.00K | -952.00K | -952.00K |
Total Common Equity | 56.39M | 64.87M | 74.71M | 37.21M | 18.86M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 56.39M | 64.87M | 74.71M | 37.21M | 18.86M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 56.39M | 64.87M | 74.71M | 37.21M | 18.86M |
|